文献速递烧伤创面修复

富血小板血浆与富含生长因子血浆用于烧伤患者刃厚皮片供区治疗的随机临床试验

Platelet rich plasma and plasma rich in growth factors for split-thickness skin graft donor site treatment in the burn patient setting: A randomized clinical trial.
PubMed 文献 · Burns · 2021-10-22

该随机临床试验以自身对照设计纳入20例烧伤患者共60个供区,比较富血小板血浆(PRP)、富含生长因子血浆(PRGF)与氢胶体敷料标准护理。术后第8天PRP组55%、PRGF组45%供区完全上皮化,氢胶体组为20%,后两者比较差异有统计学意义(p=0.036)。PRP与PRGF组术后第5天和第8天疼痛视觉模拟评分低于氢胶体组,PRP组创面愈合指标值低于氢胶体组,未记录不良事件。

要点

  • 术后第8天完全上皮化:PRP组55%、PRGF组45% vs 氢胶体组20%(p=0.036,后两者比较)。
  • PRP与PRGF组术后第5天和第8天疼痛视觉模拟评分低于氢胶体组。
  • PRP组创面愈合指标值低于氢胶体组,未记录不良事件。

核心结论

  • 在烧伤患者中,PRP治疗刃厚皮片供区可缩短上皮化时间。
  • 本研究中PRP组和PRGF组均观察到更好的疼痛控制和瘢痕质量。

研究设计与样本

  • 随机临床试验,每例患者自身对照,共招募20例患者、60个供区。
  • 每个患者三个供区分别接受PRP、PRGF或氢胶体标准护理。
  • PRGF由研究对象的PRP经冻融方法获得。

主要发现

  • 术后第8天,PRP组55%和PRGF组45%的供区完全上皮化,氢胶体组为20%,后两者比较差异有统计学意义(p=0.036)。
  • PRP和PRGF组术后第5天和第8天疼痛视觉模拟评分低于氢胶体组。
  • PRP组创面愈合指标值低于氢胶体组。
  • 未记录不良事件。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Management of donor site morbidity in the setting of split thickness skin graft (STSG) is of crucial importance with no superior wound dressing described to date and the growing need of decreasing epithelializing time. The purpose of the study was to compare the standard of care using a hydrocolloid dressing to platelet rich plasma (PRP) and plasma rich in growth factors (PRGF) in order to determine its therapeutic potential in this setting. METHODS: A randomized clinical trial was conducted in which each patient served as its own control. PRGF was obtained by means of freeze-thaw out of the PRP from the subject of the study. Patients from the study had three donor sites and each donor site received either to PRP, PRGF or the standard of care, hydrocolloid. The main variable was time to epithelialization, and secondary variables subject to study were pain, quality of the scar, complications and cost. RESULTS: 20 patients were recruited with a total number of 60 donor sites to study. On the 8th post-operative day 55% and 45% of the sites treated with PRP and PRGF, respectively, complete epithelialization was observed as compared to 20% of the sites treated with hydrocolloid, statistical significance was achieved between the latter two (p = 0.036). The areas treated with PRP and PRGF received inferior values on the visual analog scale on post-op day 5 and 8 compared to hydrocolloid. Values on wound healing metrics were lower in the PRP when compared to hydrocolloid. No adverse effects were recorded. CONCLUSION: Donor site of STSG treated with PRP in the setting of the burn patient decreased time to epithelialization. In our study a better pain control and in scar quality was observed in both, the PRP and PRGF group.

来源:Burns,查看原文。版权归原作者所有。

引用

  1. García-Sánchez JM, Mirabet Lis V, Ruiz-Valls A, et al. Platelet rich plasma and plasma rich in growth factors for split-thickness skin graft donor site treatment in the burn patient setting: A randomized clinical trial. Burns. 2021. PMID: 34952738. doi:10.1016/j.burns.2021.10.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。